Evidence map›Paper›PMID 30616682›Full record

ArticleStem cell research & therapy2019

Clonal derivation of white and brown adipocyte progenitor cell lines from human pluripotent stem cells.

Michael D West, Ching-Fang Chang, Dana Larocca, Jie Li, Jianjie Jiang, Pamela Sim, Ivan Labat, Karen B Chapman, Kari E Wong, James Nicoll and 5 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Michael D WestAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
Ching-Fang ChangUniversity of California, Berkeley, CA, 94720, USA.
Dana LaroccaAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA. dlarocca@agexinc.com.
Jie LiAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
Jianjie JiangAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
Pamela SimAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
Ivan LabatAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
Karen B ChapmanJohns Hopkins University, Baltimore, MD, 21218, USA.
Kari E WongMetabolon Inc., Morrisville, NC, 27560, USA.
James NicollZen-Bio, Inc., Research Triangle Park, NC, 27709, USA.
Michael J Van KaneganZen-Bio, Inc., Research Triangle Park, NC, 27709, USA.
Aubrey D N J de GreyAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
Igor O NasonkinBioTime, Inc., Alameda, CA, 94501, USA.
Andreas StahlUniversity of California, Berkeley, CA, 94720, USA.
Hal SternbergAgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
University of California, Berkeley · USJohns Hopkins University · USLineage Cell Therapeutics (United States) · USMetabolon (United States) · USSENS Research Foundation · USTriangle · USZen Bio (United States) · US

Funding

Cellular mechanobiology and engineering of active brown adipose tissueR01DK118940 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI KUMAR, SANJAY, STAHL, ANDREAS · 2019 to 2022
$2.3M
Cellular mechanobiology and engineering of active brown adipose tissueR56DK118940 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI KUMAR, SANJAY, STAHL, ANDREAS · 2018 to 2018
$389k
NIDDK NIH HHS R01 DK118940NIDDK NIH HHS R56 DK118940
6 · The paper itself

Abstract

backgroundThe role of brown fat in non-shivering thermogenesis and the discovery of brown fat depots in adult humans has made it the subject of intense research interest. A renewable source of brown adipocyte (BA) progenitors would be highly valuable for research and therapy. Directed differentiation of human pluripotent stem (hPS) cells to white or brown adipocytes is limited by lack of cell purity and scalability. Here we describe an alternative approach involving the identification of clonal self-renewing human embryonic progenitor (hEP) cell lines following partial hPS cell differentiation and selection of scalable clones.

methodsWe screened a diverse panel of hPS cell-derived clonal hEP cell lines for adipocyte markers following growth in adipocyte differentiation medium. The transcriptome of the human hES-derived clonal embryonic progenitor cell lines E3, C4ELS5.1, NP88, and NP110 representing three class of definitive adipocyte progenitors were compared to the relatively non-adipogenic line E85 and adult-derived BAT and SAT-derived cells using gene expression microarrays, RT-qPCR, metabolic analysis and immunocytochemistry. Differentiation conditions were optimized for maximal UCP1 expression.

resultsMany of the differentiated hEP cell lines expressed the adipocyte marker, FAPB4, but only a small subset expressed definitive adipocyte markers including brown adipocyte marker, UCP1. Class I cells (i.e., E3) expressed CITED1, ADIPOQ, and C19orf80 but little to no UCP1. Class II (i.e., C4ELS5.1) expressed CITED1 and UCP1 but little ADIPOQ and LIPASIN. Class III (i.e., NP88, NP110) expressed CITED1, ADIPOQ, C19orf80, and UCP1 in a similar manner as fetal BAT-derived (fBAT) cells. Differentiated NP88 and NP110 lines were closest to fBAT cells morphologically in adiponectin and uncoupling protein expression. But they were more metabolically active than fBAT cells, had higher levels of 3-hydroxybutyrate, and lacked expression of fetal/adult marker, COX7A1. The hEP BA progenitor lines were scalable to 17 passages without loss of differentiation capacity and could be readily rederived.

conclusionsTaken together, these data demonstrate that self-renewing adipocyte progenitor cells can be derived from hES cells and that they are functionally like BAT cells but with unique properties that might be advantageous for basic research and for development of cell-based treatments for metabolic diseases.

Indexed as

Adipocytes, BrownAdipocytes, WhiteCell LineEmbryonic Stem CellsHumansPluripotent Stem Cells

Identifiers

PMID30616682
PMCPMC6323697
OpenAlexW2914814712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.